Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discovery of myopodin methylation in bladder cancer

13 Jun 2008

Abstract excerpt

Myopodin is an actin-binding protein that shuttles between the nucleus and the cytoplasm. After identifying an enriched CpG island encompassing the transcription site of myopodin, we aimed at evaluating the potential relevance of myopodin methylation in bladder cancer. The epigenetic silencing of myopodin by hypermethylation was tested in bladder cancer cells (n=12) before and after azacytidine treatment....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18636402
DOI: 10.1002/path.2390

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discovery of myopodin methylation in bladder cancerPMID 18636402Read ↗

Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor MarkersSemantic proximity Read ↗

A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancerSemantic proximity Read ↗

Epigenetic Inactivation of <i>SFRP</i> Genes and TP53 Alteration Act Jointly as Markers of Invasive Bladder CancerSemantic proximity Read ↗

Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder CancerSemantic proximity Read ↗

Clinical and Prognostic Significance of Protocadherin-10 (PCDH10) Promoter Methylation in Bladder CancerSemantic proximity Read ↗

Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancerSemantic proximity Read ↗

DNA Methylation as a Therapeutic Target for Bladder CancerSemantic proximity Read ↗

Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.Semantic proximity Read ↗

Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinomaSemantic proximity Read ↗

DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarraysSemantic proximity Read ↗

CpG hypermethylation of promoter region and inactivation of E‐cadherin gene in human bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.